This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
pharmacy-bizHealthylife offers generic atomoxetine S4 (60mg) that is both brand and generic. Healthylife provides generic atomoxetine S4 (60mg) that is both brand and generic. If you are uncertain the specific content of a product information leaflet, consult the manufacturer's billing information and, if not, can contact verify the information by checking out theHealthylife.com.au.
atomoxetine (60mg) is a selective norepinephrine reuptake inhibitor (SNRI) medication belonging to the class of norepinephrine reuptake inhibitors (NREI). It works by increasing levels of norepinephrine (a neurotransmitter) in the brain, thereby reducing symptoms of attention-deficit/hyperactivity disorder (ADHD) and impulsive behavior. Atomoxetine is also used to treat other conditions such as attention deficit hyperactivity disorder (ADHD) in children. If you are uncertain the specific content of a product information leaflet, consult the manufacturer's billing information and, if not, can contact via checking out the Healthylife.com.au.
Healthylife is not responsible for any side effects or adverse reactions that may be associated with the use of this medication. If you believe your medical condition has been caused by healthylife's negligence, kindly contact the manufacturer's via Healthylife.
atomoxetine (60mg) is a selective norepinephrine reuptake inhibitor (SNRI) medication belonging to the norepinephrine reuptake inhibitors (NOREIs). If you are uncertain the specific content of a product information leaflet, consult the manufacturer's billing information and, if not, can contact via checking out the Healthylife.
atomoxetine (60mg) is taken orally, preferably with food or on a full stomach. It is important not to skip doses without consulting a healthcare professional. If you miss a dose, skip it and continue with your regular schedule. Do not take a double dose to make up for a missed one.
If you are uncertain the specific content of a product information leaflet, contact the manufacturer's via Bazaarvoice. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer's via Healthylife.
healthylife offers generic atomoxetine S4 (60mg) that is both brand and generic.
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
pharmacy online store| Brand | Healthylife |
| Active ingredient | Strattera Atomoxetine (60mg) |
| Quantity | 15 capsules |
| Type | Prescription only |
| Country of Origin | Rest of the year |
| Last Updated | 20 January 2023 |
Healthylife provides generic medication information supplements only. If you have any questions about your prescription, please contact your doctor.
Healthylife does not represent that Healthylife.com.au is a trustworthy and reliable source for prescription medication information. If you are a Australian or New Zealand citizen, you can also visit the Healthylife website at or call our 24/7 toll-free service.
Strattera Atomoxetine is a medication used to treat attention deficit hyperactivity disorder (ADHD) in adults.
Strattera Atomoxetine (60mg) can start to work within 15 to 30 minutes of oral ingestion. However, it is important to note that Strattera may take longer to start working if you take it with a high-fat meal.
Strattera Atomoxetine (60mg) is an attention deficit hyperactivity disorder (ADHD) medication used to treat adults with ADHD.
Yes, Strattera Atomoxetine (60mg) is available over the counter in Australia. If you have questions about obtaining Strattera Atomoxetine (60mg) over the counter in Australia, contact your doctor.
If you are a New Zealand citizen, you can also visit Healthylife website at or call our 24/7 toll-free service.
Strattera Atomoxetine (60mg) can last up to 4 - 6 hours, depending on the dosage and the condition it is used to treat.
Attention deficit hyperactivity disorder (ADHD) is one of the most prevalent mental health disorders in the United States. The global prevalence of ADHD is estimated to reach approximately 20% to 30% by the year 2027. The symptoms of ADHD can be broadly classified into four main groups: hyperactivity (high,idgeting, hyperactive-impulsive), irritability, and impulsivity. In the United States, the total prevalence of ADHD in children aged 8–17 years is estimated to be 2.2% (2027).
The primary symptoms of ADHD are hyperactivity (high,idgeting, hyperactive-impulsivity) and irritability (high, irritability), with symptoms increasing in the first years of life. ADHD is classified as a disorder with a significant impact on daily life, including academic, social, and occupational functioning. The most common types of ADHD are the heterogeneous nature of ADHD and its symptoms, such as inattention, hyperactivity, impulsivity, hyperactivity, impulsivity-related problems, and hyperactivity and impulsivity-related symptoms.
The symptoms of ADHD can be broadly classified into four main types based on the underlying cause and severity of ADHD. The first two types of ADHD include inattentive-impulsivity (AIMS), hyperactive-impulsivity-hyperactivity (HIMPA), and hyperactive-impulsivity-related symptoms (ADHD-related symptoms). The fifth type of ADHD includes hyperactivity and impulsivity-related inattentive symptoms (HSSS). Both of these types of symptoms have a significant impact on daily functioning, academic performance, and academic outcomes. Hyperactivity and impulsivity are the two most common types of ADHD.
The prevalence of hyperactivity and impulsivity in children with ADHD varies considerably. For example, the prevalence of hyperactivity in children aged 7–16 years ranges from 2.2% to 11.7% (2027) (see Table 1).
Table 1
Differences of Hyperactivity and Risks
For adults with ADHD, the risk of ADHD-related side effects increases with age. The risk of AIMS in adults increases with age from a mean of 4.6% for children aged 8–17 years to 16.8% for children aged 10–14 years (2027) (Table 2). The increase in risk of AIMS in children aged 7–16 years was observed in patients diagnosed with ADHD in a large population-based study conducted in 2013 (2027).
The risk of AIMS increases with age from a mean of 4.6% for children aged 8–17 years to 8.3% for children aged 10–14 years (2027) (Table 3).
For children aged 7–16 years, the risk of hyperactivity and inattention increases with age, from a mean of 8.3% for children aged 7–16 years to 12.1% for children aged 10–14 years (2027) (see Table 4).
For children aged 10–14 years, the risk of ADHD-related symptoms increases with age, from a mean of 6.4% for children aged 10–14 years to 5.8% for children aged 15–17 years (2027) (Table 4).
In the U. S., ADHD-related symptoms are the most common types of symptoms of ADHD, with hyperactivity, inattention, and impulsivity as the most common type (Table 5).
Table 5
Risk Factors for ADHD
There are several risk factors for hyperactivity and impulsivity, which can be grouped into the following categories:
The risk of ADHD-related symptoms increases with age from a mean of 7.2% for children aged 7–16 years to 16.8% for children aged 10–14 years (2027) (see Table 6).
Strattera (Dopamine), a medication for dogs that is commonly prescribed for attention-deficit hyperactivity disorder (ADHD), is a selective norepinephrine reuptake inhibitor (SNRI). This drug is available as a generic drug and has a number of generic formulations, including the brand name Doxepin, and is marketed as a generic medication for dogs. In addition to being a prescription drug, Doxepin is available as a non-prescription drug and is sold under many different brand names. In dogs, Doxepin is used to treat dogs diagnosed with Attention-Deficit Hyperactivity Disorder (ADHD), which is a behavior disorder that is characterized by difficulty focusing, repetitive activities, and/or excessive restfulness. In some cases, it can also be prescribed for dogs diagnosed with canine hyperactive behavior disorder (AHD).
In addition to the generic form of Doxepin, other brand names of the drug include:,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,citationfor more information.
Doxepin is the generic form of Doxepin, which is sold under the brand name GlaxoSmithKline. In addition to the brand name Doxepin, it also has the generic name Dexedrine, which is also sold under the brand name Dexedrine Extended-Release. This drug is available in generic form, and is manufactured by several different manufacturers and distributors, including the brand name Apomorphine. In dogs, Dexedrine is used to treat dogs diagnosed with canine hyperactive behavior disorder (AHD) and for the treatment of dogs diagnosed with canine hyperactive behavior disorder (AHD) in the following three treatment regimens:
Stade de France Pharmacy